Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06698003
What this trial is testing

Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Who this might be right for
T-Cell Leukemia/Lymphoma, AdultT-cell Leukemia/LymphomaT-cell Leukemia+1 more
Memorial Sloan Kettering Cancer Center 134
Testing effectiveness (Phase 2)Study completedNCT03490344
What this trial is testing

Short Course Daratumumab in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)Active Not RecruitingNCT03422393
What this trial is testing

Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Michael Choi 24
Testing effectiveness (Phase 2)WithdrawnNCT02053545
What this trial is testing

Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion

Who this might be right for
LeukemiaLymphomaMDS
Ann & Robert H Lurie Children's Hospital of Chicago
Not applicableWithdrawnNCT00900445
What this trial is testing

Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaUntreated Childhood Acute Lymphoblastic Leukemia
Children's Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01181271
What this trial is testing

Tandem Auto-Allo Transplant for Lymphoma

Who this might be right for
Diffuse, Large B-Cell, LymphomaLymphoma, Low-GradeT-Cell Lymphoma+4 more
Massachusetts General Hospital 42
Large-scale testing (Phase 3)WithdrawnNCT07428369
What this trial is testing

Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM)

Who this might be right for
Multiple Myeloma (MM)
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01422603
What this trial is testing

Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid LeukaemiaMyelodysplasia
University Hospital Southampton NHS Foundation Trust 9
Early research (Phase 1)Study completedNCT02697383
What this trial is testing

Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study

Who this might be right for
Multiple MyelomaHigh Risk Smoldering Multiple Myeloma
Memorial Sloan Kettering Cancer Center 14
Testing effectiveness (Phase 2)UnknownNCT03083054
What this trial is testing

Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
University of Campinas, Brazil 5
Testing effectiveness (Phase 2)Looking for participantsNCT04169737
What this trial is testing

Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia+1 more
M.D. Anderson Cancer Center 168
Testing effectiveness (Phase 2)Ended earlyNCT03850522
What this trial is testing

PD-L1 Peptide Vaccination in High Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Lene Meldgaard Knudsen 6
Testing effectiveness (Phase 2)Study completedNCT00886522
What this trial is testing

Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies

Who this might be right for
Hematological Malignancies
IRCCS Azienda Ospedaliero-Universitaria di Bologna 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT07779031
What this trial is testing

A Single-Arm, Open Phase I Clinical Study of Selinexor in Combination With Azacitidine for the Treatment of High-Risk AML/MDS Patients After Allo-HSCT

Who this might be right for
Acute Myeloid Leukaemia (AML)MDS (Myelodysplastic Syndrome)
Liping Dou 58
Testing effectiveness (Phase 2)Ended earlyNCT02229266
What this trial is testing

Randomised Controlled Phase-2 Trial to Determine the Efficacy of Adoptive Immunotherapy With NK Cells in High-risk AML

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 1
Large-scale testing (Phase 3)Looking for participantsNCT03793517
What this trial is testing

Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT

Who this might be right for
Stem Cell Transplant ComplicationsLeukemia, Myeloid, AcuteLeukemia Relapse
Peking University People's Hospital 55
Testing effectiveness (Phase 2)Study completedNCT00003658
What this trial is testing

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 60
Testing effectiveness (Phase 2)Ended earlyNCT02573935
What this trial is testing

Clarithromycin in Multiple Myeloma Induction Therapy

Who this might be right for
Multiple Myeloma
Henrik Gregersen 58
Not applicableLooking for participantsNCT07613385
What this trial is testing

Individualized AML Treatment

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (AML)
City of Hope Medical Center 18
Large-scale testing (Phase 3)Study completedNCT00165178
What this trial is testing

Treatment of Acute Lymphoblastic Leukemia in Children

Who this might be right for
Acute Lymphoblastic Leukemia
Dana-Farber Cancer Institute 498
Next Page